Ebeling, Peter

Prof Peter Ebeling AO

Endocrinologist; Head, Department of Medicine, School of Clinical Sciences, Monash Health, Monash University
Professor Peter Ebeling AO, is Head of the Department of Medicine in the School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences. He was also inaugural Director of the Australian Institute of Musculoskeletal Science (AIMSS).

Research interests include musculoskeletal health and diseases; public health aspects of vitamin D, including effects on muscle function, bone and diabetes; post-transplantation osteoporosis; and osteoporosis in men. Professor Ebeling was Associate Editor of Journal of Bone and Mineral Research from 2008-2012. He currently serves on the Editorial Board of Osteoporosis International and is Editor of Clinical Endocrinology (Oxf) and is Editor-in-Chief of JBMR Plus. He is Medical Director of Osteoporosis Australia; Board Member, International Osteoporosis Foundation; Past-President, Endocrine Society of Australia; Past-President of the Australian and New Zealand Bone and Mineral Society; and Councillor, American Society of Bone and Mineral Research, only the third Australian to be elected. He serves on the NHMRC Research Committee from 2015-2018. He has over 320 peer-reviewed publications, including in the New England Journal of Medicine, PNAS and Science. He also teaches and mentors medical students, and supervises a number of Research Higher Degree students, and advanced physician trainees in Endocrinology.

More from this expert

The pros and cons of the various treatments for osteoporosis

Podcasts iconPodcasts

Prof Ebeling AO explains who is truly at risk, when to check levels and how to optimise vitamin D status in everyday general practice.

Podcasts iconPodcasts

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.